ExLibris header image
SFX Logo
Title: Medical research: Ebola therapy protects severely ill monkeys
Source:

Nature [0028-0836] Geisbert, T W yr:2014


Collapse list of basic services Basic
Full text
Full text available via Nature
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Qiu, X. "Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp." Nature 514.7520 (2014): 47-53. Link to Full Text for this item Link to SFX for this item
2. Qiu, X. "mAbs and Ad-Vectored IFN-  Therapy Rescue Ebola-Infected Nonhuman Primates When Administered After the Detection of Viremia and Symptoms." Science translational medicine 5.207 (2013): 207-207. Link to SFX for this item
3. Vogel, G. "Infectious Disease. Genomes reveal start of Ebola outbreak." Science 345.6200 (2014): 989-90. Link to SFX for this item
4. Feldmann, H. "Ebola haemorrhagic fever." Lancet 377.9768 (2010): 849-862. Link to SFX for this item
5. Zhou, J. "Nanoparticle-based delivery of RNAi therapeutics: Progress and challenges." Pharmaceuticals 6.1 (2013): 85-107. Link to Full Text for this item Link to SFX for this item
6. Leroy, Eric M M. "Fruit bats as reservoirs of Ebola virus." Nature 438.7068 (2006): 575-6. Link to Full Text for this item Link to SFX for this item
7. McCarthy, M. "US signs contract with ZMapp maker to accelerate development of the Ebola drug." BMJ. British medical journal 349.sep04 10 (2014). Link to SFX for this item
8. Zeitlin, L. "Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant." Proceedings of the National Academy of Sciences of the United States of America 108.51 (2011): 20690-20694. Link to Full Text for this item Link to SFX for this item
9. Qiu, X. "Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies." Clinical immunology 141.2 (2011): 218-227. Link to SFX for this item
10. Pettitt, J. "Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail." Science translational medicine 5.199 (2013): 199-199. Link to SFX for this item
11. Gire, R. S. G. K. "Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak." Science 345.6202 (2014): 1369-72. Link to SFX for this item
12. Sobarzo, A. "Persistent immune responses after Ebola virus infection." The New England journal of medicine 369.5 (2013): 492-493. Link to SFX for this item
13. Hoenen, T. "Ebola virus: unravelling pathogenesis to combat a deadly disease." Trends in molecular medicine 12.5 (2006): 206-15. Link to SFX for this item
14. Olinger, Gene G. "Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques." Proceedings of the National Academy of Sciences of the United States of America 109.44 (2012): 18030-18035. Link to Full Text for this item Link to SFX for this item
15. Konduru, K. "Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice." Vaccine 29.16 (2011): 2968-77. Link to SFX for this item
16. LeDuc, J W W. "An introduction to Ebola: the virus and the disease." The journal of infectious diseases 179 Suppl 1.1 (1999): 170-176. Link to SFX for this item
17. Michaud, J. "The 2014 Ebola Outbreak." JAMA: the Journal of the American Medical Association 312.14 (2014): 1388-1388. Link to SFX for this item
18. Check Hayden, E. "World struggles to stop Ebola." Nature 512.7515 (2014): 355-356. Link to Full Text for this item Link to SFX for this item
19. Enserink, M. "Infectious diseases. Debate erupts on 'repurposed' drugs for Ebola." Science 345.6198 (2014): 718-9. Link to SFX for this item
20. Takada, A. "Ebola and Marburg virus diseases in Africa: Increased risk of outbreaks in previously unaffected areas?" Microbiology and immunology 58.9 (2014): 483-491. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced